Rupatadine oral solution for 2–5-year-old children with allergic rhinitis: a safety, open-label, prospective study

Rupatadine oral solution for 2–5-year-old children with allergic rhinitis: a safety, open-label, prospective study

Eva Santamaría,1,2 Iñaki Izquierdo,2 Marta Valle,1,3 Jan Vermeulen,4 Paul Potter5 1Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain; 2Clinical Development, R&D, J. Uriach y Compañ&iac...

Full description

Bibliographic Details
Main Authors: Santamaría E, Izquierdo I, Valle M, Vermeulen J, Potter P
Format: Article
Language:English
Published: Dove Medical Press 2018-09-01
Series:Journal of Asthma and Allergy
Subjects:
allergic rhinitis
children
antihistamines
safety
rupatadine.
Online Access:https://www.dovepress.com/rupatadine-oral-solution-for-2-5-year-old-children-with-allergic-rhini-peer-reviewed-article-JAA

Internet

https://www.dovepress.com/rupatadine-oral-solution-for-2-5-year-old-children-with-allergic-rhini-peer-reviewed-article-JAA

Similar Items